Here's Why Myriad Genetics Is Down 26% in 2016

Here's Why Myriad Genetics Is Down 26% in 2016·Motley Fool

A combination of disappointing guidance and increasing competition has resulted in a painful 2016 for Myriad Genetics investors, but there are reasons for optimism.

Advertisement